Works matching DE "CANADIAN Agency for Drugs %26 Technologies in Health"

Results: 31

Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost.

Published in:

2017

By:

Rawson, Nigel S. B.

Publication type:

Letter

Health technology assessment of drugs for rare diseases: insights, trends, and reasons for negative recommendations from the CADTH common drug review.

Published in:

Orphanet Journal of Rare Diseases, 2016, v. 11, p. 1, doi. 10.1186/s13023-016-0539-3

By:

Janoudi, Ghayath;
Amegatse, William;
McIntosh, Brendan;
Sehgal, Chander;
Richter, Trevor

Publication type:

Article

Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

Published in:

2024

By:

Mirzayeh Fashami, Fatemeh;
Tarride, Jean-Eric;
Sadeghirad, Behnam;
Hariri, Kimia;
Peyrovinasab, Amirreza;
Levine, Mitchell

Publication type:

Correction Notice

Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 6, p. 823, doi. 10.1007/s41669-024-00511-9

By:

Mirzayeh Fashami, Fatemeh;
Tarride, Jean-Eric;
Sadeghirad, Behnam;
Hariri, Kimia;
Peyrovinasab, Amirreza;
Levine, Mitchell

Publication type:

Article

Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory study.

Published in:

CMAJ Open, 2016, v. 4, n. 4, p. E674, doi. 10.9778/cmajo.20160006

By:

Allen, Nicola;
Walker, Stuart R.;
Liberti, Lawrence;
Sehgal, Chander;
Salek, M. Sam

Publication type:

Article

Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021.

Published in:

Current Oncology, 2022, v. 29, n. 11, p. 8031, doi. 10.3390/curroncol29110635

By:

Lau, Catherine;
Dranitsaris, George

Publication type:

Article

Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia.

Published in:

Current Oncology, 2022, v. 29, n. 10, p. 7624, doi. 10.3390/curroncol29100602

By:

Ball, Graeme;
Levine, Mitchell A. H.;
Thabane, Lehana;
Tarride, Jean-Eric

Publication type:

Article

Clinician participation in CADTH's pan-Canadian Oncology Drug Review: contribution and impact on cancer drug funding recommendations.

Published in:

Current Oncology, 2017, v. 24, n. 2, p. 71, doi. 10.3747/co.24.3644

By:

Trudeau, M.;
Hoskins, P.;
Reiman, T.;
Chambers, A.;
Mai, H.;
Wheatley-Price, P.

Publication type:

Article

Network meta-analysis: an introduction for pharmacists.

Published in:

2018

By:

Xu, Yina;
Amiche, Mohamed Amine;
Tadrous, Mina

Publication type:

journal article

The Rx for Change database: a first-in-class tool for optimal prescribing and medicines use.

Published in:

2010

By:

Weir, Michelle C.;
Ryan, Rebecca;
Mayhew, Alain;
Worswick, Julia;
Santesso, Nancy;
Lowe, Dianne;
Leslie, Bill;
Stevens, Adrienne;
Hill, Sophie;
Grimshaw, Jeremy M.

Publication type:

journal article

ENVIRONMENTAL IMPACT ASSESSMENT OF A HEALTH TECHNOLOGY: A SCOPING REVIEW.

Published in:

2018

By:

Polisena, Julie;
De Angelis, Gino;
Kaunelis, David;
Gutierrez-Ibarluzea, Iñaki;
Gutierrez-Ibarluzea, Iñaki

Publication type:

journal article

USING THE INTEGRATE-HTA GUIDANCE: EXPERIENCE FROM CADTH.

Published in:

International Journal of Technology Assessment in Health Care, 2017, v. 33, n. 5, p. 591, doi. 10.1017/S0266462317000940

By:

Bond, Ken;
Weeks, Laura

Publication type:

Article

OP100 How Health Technology Assessment Is Adapting To Orphan Drugs In Canada – Not!

Published in:

2017

By:

Mills, Ferg;
Wong-Rieger, Durhane

Publication type:

Abstract

RAPID REVIEW: AN EMERGING APPROACH TO EVIDENCE SYNTHESIS IN HEALTH TECHNOLOGY ASSESSMENT.

Published in:

International Journal of Technology Assessment in Health Care, 2014, v. 30, n. 1, p. 20, doi. 10.1017/S0266462313000664

By:

Khangura, Sara;
Polisena, Julie;
Clifford, Tammy J.;
Farrah, Kelly;
Kamel, Chris

Publication type:

Article

HEALTH TECHNOLOGY REASSESSMENT: THE ART OF THE POSSIBLE.

Published in:

International Journal of Technology Assessment in Health Care, 2013, v. 29, n. 4, p. 418, doi. 10.1017/S0266462313000494

By:

MacKean, Gail;
Noseworthy, Tom;
Elshaug, Adam G.;
Leggett, Laura;
Littlejohns, Peter;
Berezanski, Joan;
Clement, Fiona

Publication type:

Article

Priority setting for health technology assessment at CADTH.

Published in:

International Journal of Technology Assessment in Health Care, 2010, v. 26, n. 3, p. 341, doi. 10.1017/S0266462310000383

By:

Husereau, Don;
Boucher, Michel;
Noorani, Hussein

Publication type:

Article

Factors associated with positive and negative recommendations for cancer and non-cancer drugs for rare diseases in Canada.

Published in:

2019

By:

Nagase, Fernanda Naomi Inagaki;
Stafinski, Tania;
Sun, Jian;
Jhangri, Gian;
Menon, Devidas

Publication type:

journal article

A pragmatic critical appraisal instrument for search filters: introducing the CADTH CAI.

Published in:

Health Information & Libraries Journal, 2009, v. 26, n. 3, p. 211, doi. 10.1111/j.1471-1842.2008.00830.x

By:

Bak, Greg;
Mierzwinski-Urban, Monika;
Fitzsimmons, Hayley;
Morrison, Andra;
Maden-Jenkins, Michelle

Publication type:

Article

Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs.

Published in:

2019

By:

Costa, Sarah;
Bentley, Colene;
Regier, Dean A.;
McTaggart-Cowan, Helen;
Mitton, Craig;
Burgess, Michael M.;
Peacock, Stuart J.

Publication type:

journal article

Erratum to: Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review.

Published in:

2017

By:

Zarin, Wasifa;
Veroniki, Areti Angeliki;
Nincic, Vera;
Vafaei, Afshin;
Reynen, Emily;
Motiwala, Sanober S;
Antony, Jesmin;
Sullivan, Shannon M;
Rios, Patricia;
Daly, Caitlin;
Ewusie, Joycelyne;
Petropoulou, Maria;
Nikolakopoulou, Adriani;
Chaimani, Anna;
Salanti, Georgia;
Straus, Sharon E;
Tricco, Andrea C

Publication type:

journal article

Reducing Test Utilization in Hospital Settings: A Narrative Review.

Published in:

Annals of Laboratory Medicine, 2018, v. 38, n. 5, p. 402, doi. 10.3343/alm.2018.38.5.402

By:

Bindraban, Renuka S.;
ten Berg, Maarten J.;
Naaktgeboren, Christiana A.;
Kramer, Mark H. H.;
van Solinge, Wouter W.;
Nanayakkara, Prabath W. B.

Publication type:

Article

CADTH Examines Cancer Risk from Dental X-rays.

Published in:: Journal of the Canadian Dental Association, 2012, v. 78, p. 1
Publication type:: Article

Patients seeking more involvement at medical meetings.

Published in:

2018

By:

Rich, Pat

Publication type:

journal article

Opioids and pharmacare top of mind at annual CADTH meeting.

Published in:

2018

By:

Rich, Pat

Publication type:

journal article

Low awareness about CADTH among practising doctors in Canada.

Published in:

2018

By:

Rich, Pat

Publication type:

journal article

New guidelines for evaluating health tech.

Published in:

2017

By:

Moulton, donalee

Publication type:

journal article

A decade of the Common Drug Review.

Published in:

Canadian Medical Association Journal (CMAJ), 2013, v. 185, n. 7, p. E277, doi. 10.1503/cmaj.109-4428

By:

Spitz, Sarah

Publication type:

Article

A decade of the Common Drug Review.

Published in:

Canadian Medical Association Journal (CMAJ), 2013, v. 185, n. 7, p. 554, doi. 10.1503/cmaj.109-4443

By:

Spitz, Sarah

Publication type:

Article

Response to the Canadian Agency for Drugs and Technologies in Health and Institut national d'excellence en santé et en services sociaux decision regarding nusinersen for Spinal Muscular Atrophy.

Published in:

Canadian Journal of Neurological Sciences, 2018, v. 45, n. 5, p. 516, doi. 10.1017/cjn.2018.59

By:

Campbell, Craig;
Selby, Kathy;
McMillan, Hugh;
Vajsar, Jiri;
Korngut, Lawrence;
Brais, Bernard;
MacKenzie, Alex;
Oskoui, Maryam

Publication type:

Article

Update on the Use of SSRls and SNRIs with Children and Adolescents in Clinical Practice.

Published in:

Journal of the Canadian Academy of Child & Adolescent Psychiatry, 2016, v. 25, n. 1, p. 4

By:

Jane Garland, E.;
Kutcher, Stan;
Virani, Adil;
Elbe, Dean

Publication type:

Article

Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?

Published in:

Health & Quality of Life Outcomes, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7525-11-71

By:

Kuspinar, Ayse;
Mayo, Nancy E.

Publication type:

Article